FMC Earnings Prediction
The chart below shows how FMC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, FMC sees a +1.37% change in stock price 10 days leading up to the earnings, and a -6.20% change 10 days following the report. On the earnings day itself, the stock moves by -0.57%. This data can give you a slight idea of what to expect for the next quarter's release.
FMC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.22B
6.82%
14.91%
Gross Margin
42.86%
12.73%
18.17%
Operating Margin
18.30%
-35.06%
9.32%
Net Margin
2.39%
-97.63%
-61.70%
EPS
-0.13
-101.48%
-125.00%
No Data Available
FMC Earnings Analysis
FMC Corp Corporation (FMC.N) Earnings Conference Call
Positive
Earnings Per Share Beat: FMC Corporation reported Q4 2024 EPS of $1.79, exceeding expectations of $1.65, reflecting strong financial performance.
Q4 Revenue Increase: Q4 revenue reached $1.22 billion, a 7% increase year-over-year, driven primarily by volume gains in the growth portfolio, which accounted for over 75% of the growth.
Record EBITDA Growth: Fourth quarter EBITDA was $339 million, representing a 33% increase compared to the previous year, and achieving an all-time high EBITDA margin of 27.7%.
Free Cash Flow Surge: Free cash flow for full-year 2024 was $614 million, an increase of more than $1.1 billion compared to the prior year, driven by improved cash from operations and reduced capital expenditures.
Growth Portfolio Projections: The growth portfolio is expected to grow at an annual rate of about 24% from 2024 to 2027, with new active ingredients projected to reach $600 million in sales by 2027.
Negative
Q4 Revenue Shortfall: Q4 revenue of $1.22 billion was below guidance, indicating a need for aggressive actions to reposition FMC and lower channel inventory significantly.
Sales Forecast Overview: 2025 sales are expected to be flat to prior year at the midpoint, with a forecasted decline of 16% in Q1 due to negative pricing, FX, and volume impacts.
Sales Decline Challenges: Full-year 2024 sales declined 5% as lower pricing and FX headwinds offset higher volume gains, indicating challenges in maintaining revenue growth.
EBITDA Impact from FX Headwinds: 2025 EBITDA is projected to be negatively impacted by $65 million to $75 million from FX headwinds, reflecting a more normalized relationship between FX impacts and EBITDA compared to 2024.
Free Cash Flow Decline: Free cash flow for 2025 is expected to decrease by $314 million at the mid-point, indicating a significant drop in cash generation capabilities compared to 2024.
FMC FAQs
How does FMC typically perform around its earnings report dates?
Is FMC Corp (FMC) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
FMC Earning Call Sentiment
FMC Corporation (NYSE:FMC) Q4 2024 Earnings Call Transcript
FMC.N
-1.31%Positive
The earnings call presents a mixed outlook. Strong Q4 financials with record EBITDA margins and significant EPS growth are positive, but full-year declines in revenue and EBITDA, along with weak guidance, create concerns. The restructuring and new product sales offer potential, but competitive pressures and pricing issues, especially with Rynaxypyr, are risks. The Q&A reveals cautious optimism but also lacks clarity on key issues. Without explicit shareholder return plans and considering the market's uncertainties, the overall sentiment remains neutral, with a balanced outlook on short-term stock price movement.
